Adverse effect of anticoag antag, vit K and oth coag, subs

This code signifies a patient experiencing an unintended and undesirable reaction from the therapeutic use of medications designed to reverse anticoagulation, such as vitamin K or other procoagulant agents. It indicates that the patient is in the recovery phase or receiving ongoing treatment for the adverse effect, rather than the initial acute presentation.

Apply this code when documenting follow-up care for complications arising from the administration of anticoagulant reversal agents. This includes subsequent visits for monitoring, managing persistent symptoms, or treating sequelae of the adverse effect, such as a rebound thrombotic event after vitamin K administration.

• Ensure the encounter is for ongoing management or recovery, not the initial treatment of the adverse effect.
• Always code the specific adverse effect(s) first, followed by this code as a secondary diagnosis.
• Distinguish carefully from poisoning (T36-T65) or underdosing (T45.7X6-).